Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
09 December 2024
Events
Navigating the Complex Landscape of Cybersecurity and Data Privacy in the Timeshare Industry
Aaron Tantleff (Partner, Chicago) will be joining the American Resort Development Association (ARDA) for their webinar, “Navigating the Complex Landscape of Cybersecurity and Data Privacy in the Timeshare Industry.”
22 November 2024
Foley Viewpoints
DOJ’s Antitrust Division Says Compliance Programs Must be Updated to Address Changing Technology
In November 2024, the U.S. Department of Justice Antitrust Division updated its guidance on how it will evaluate Corporate Compliance Programs when conducting criminal antitrust investigations.
21 November 2024
Foley Viewpoints
Defined Benefit Pension Plans’ Annual Funding Notices Will Look Different in 2025
Most SECURE 2.0 articles focus on the changes applicable to defined contribution plans, such as 401(k) plans, and rightly so, since those plans were the most impacted by the law.